De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies

…, E Goldmuntz, RP Lifton, CE Seidman, WK Chung - Science, 2015 - science.org
Congenital heart disease (CHD) patients have an increased prevalence of extracardiac
congenital anomalies (CAs) and risk of neurodevelopmental disabilities (NDDs). Exome …

Phenotypes of Mouse diabetes and Rat fatty Due to Mutations in the OB (Leptin) Receptor

SC Chua Jr, WK Chung, XS Wu-Peng, Y Zhang, SM Liu… - Science, 1996 - science.org
Mice harboring mutations in the obese (ob) and diabetes (db) genes display similar phenotypes,
and it has been proposed that these genes encode the ligand and receptor, respectively…

[HTML][HTML] A novel channelopathy in pulmonary arterial hypertension

…, JE Loyd, RS Kass, WK Chung - … England Journal of …, 2013 - Mass Medical Soc
Background Pulmonary arterial hypertension is a devastating disease with high mortality.
Familial cases of pulmonary arterial hypertension are usually characterized by autosomal …

Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

…, CM Kets, MA Adank, EM John, WK Chung… - Jama, 2017 - jamanetwork.com
Importance The clinical management ofBRCA1andBRCA2mutation carriers requires accurate,
prospective cancer risk estimates. Objectives To estimate age-specific risks of breast, …

[HTML][HTML] Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2. 0): a policy statement of the …

SS Kalia, K Adelman, SJ Bale, WK Chung, C Eng… - Genetics in …, 2017 - nature.com
Disclaimer: These recommendations are designed primarily as an educational resource for
medical geneticists and other healthcare providers to help them provide quality medical …

Genetics and genomics of pulmonary arterial hypertension

…, F Soubrier, RC Trembath, WK Chung - Journal of the American …, 2009 - jacc.org
Pulmonary arterial hypertension (PAH) is a rare disorder that may be hereditable (HPAH),
idiopathic (IPAH), or associated with either drug-toxin exposures or other medical conditions. …

[HTML][HTML] Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes

…, N Volfovsky, EE Eichler, Y Shen, WK Chung - Nature …, 2022 - nature.com
To capture the full spectrum of genetic risk for autism, we performed a two-stage analysis of
rare de novo and inherited coding variants in 42,607 autism cases, including 35,130 new …

Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

WK Chung, K Erion, JC Florez, AT Hattersley… - Diabetes …, 2020 - Am Diabetes Assoc
The convergence of advances in medical science, human biology, data science, and
technology has enabled the generation of new insights into the phenotype known as “diabetes.” …

ACMG SF v3. 0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and …

DT Miller, K Lee, WK Chung, AS Gordon… - Genetics in …, 2021 - nature.com
Clinicians are encouraged to document the reasons for the use of a particular procedure or
test, whether or not it is in conformance with this statement. Clinicians also are advised to …

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

…, L McCluskey, M Grossman, NA Shneider, WK Chung… - Science, 2015 - science.org
Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective
treatment. We report the results of a moderate-scale sequencing study aimed at increasing the …